The global burden of Alzheimer’s Disease, neurodegenerative disorders, and cognitive decline is massive. Alzheimer’s is the 6th leading cause of death nationwide, and the only one amongst the top ten for which there is no cure. Attempts to find a viable pharmaceutical cure have, thus far, failed, and the tolls borne by victims and family members alike remain incalculable.
Research has confirmed Alzheimer’s to have a substantial prodrome; the biologic processes underlying progressive cognitive decline may in fact commence decades before symptoms begin to manifest. The discovery of a lengthy prodrome in Alzheimer’s and other dementias is cause for hope. A prodrome represents a window of opportunity, a chance to steer neurologic aging towards health, and to modify certain etiologic factors while they remain modifiable. Such factors are tools that can be wielded to potentially significant effect in a functional medicine model centered upon prevention.
This three-module course presented by Dr. James Greenblatt presents a novel paradigm for the prevention of Alzheimer’s, as well as general cognitive decline. It examines the pathophysiology of neurodegenerative illness from a functional medicine and systems biology framework, focusing on biochemical abnormalities contributing to neuronal dysfunction that are modifiable at certain prodromal stages…and, accordingly, viable functional treatment targets. Research supporting the use
of low-dose lithium and other evidence-based nutritional interventions as part of a preventative approach will be objectively reviewed, and the mechanisms through which these interventions confer neuroprotection elucidated.
Finally, evidence-based recommendations for the use of low-dose lithium and other functional medicine treatments will be proffered, providing students with actionable information that can be incorporated into existing treatment protocols to maximize therapeutic – and cognitive – outcomes.